These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8912831)

  • 1. Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung.
    Cagle PT; Fraire AE; Greenberg SD; Cox A; Brown RW
    Hum Pathol; 1996 Nov; 27(11):1198-203. PubMed ID: 8912831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens.
    Cagle PT; Brown RW; Lebovitz RM
    Hum Pathol; 1994 May; 25(5):443-8. PubMed ID: 8200637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 immunostaining in the differentiation of inflammatory pseudotumor from sarcoma involving the lung.
    Ledet SC; Brown RW; Cagle PT
    Mod Pathol; 1995 Apr; 8(3):282-6. PubMed ID: 7617655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchioloalveolar carcinoma: diagnostic pitfalls and immunocytochemical contribution.
    Saleh HA; Haapaniemi J; Khatib G; Sakr W
    Diagn Cytopathol; 1998 Apr; 18(4):301-6. PubMed ID: 9557268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung.
    Castro CY; Coffey DM; Medeiros LJ; Cagle PT
    Ann Diagn Pathol; 2001 Oct; 5(5):274-84. PubMed ID: 11598855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.
    Mullick SS; Green LK; Ramzy I; Brown RW; Smith D; Gondo MM; Cagle PT
    Acta Cytol; 1996; 40(5):855-60. PubMed ID: 8842156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
    Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
    Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between adenomatous hyperplasia of alveolar epithelium and bronchioalveolar carcinoma].
    Zhang L; Okada Y
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):141-3. PubMed ID: 7924866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
    Wang X; Rao MS; Yeldandi AV
    Mod Pathol; 1995 Dec; 8(9):919-23. PubMed ID: 8751332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
    Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma.
    Maeda R; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2011 Apr; 6(4):743-50. PubMed ID: 21325977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
    Saad RS; Liu YL; Silverman JF
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.
    Walker C; Robertson LJ; Myskow MW; Pendleton N; Dixon GR
    Br J Cancer; 1994 Aug; 70(2):297-303. PubMed ID: 7914423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
    Kerr KM; Carey FA; King G; Lamb D
    J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung.
    Nakanishi K; Hiroi S; Kawai T; Suzuki M; Torikata C
    Hum Pathol; 1998 Mar; 29(3):235-9. PubMed ID: 9496825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases.
    Sterner DJ; Mori M; Roggli VL; Fraire AE
    Mod Pathol; 1997 May; 10(5):469-73. PubMed ID: 9160312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.